Vanguard Group Inc Virios Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Virios Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 208,883 shares of VIRI stock, worth $50,131. This represents 0.0% of its overall portfolio holdings.
Number of Shares
208,883
Previous 208,883
-0.0%
Holding current value
$50,131
Previous $119,000
15.97%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VIRI
# of Institutions
22Shares Held
681KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA174KShares$41,8720.0% of portfolio
-
State Street Corp Boston, MA52.8KShares$12,6780.0% of portfolio
-
Mc Collum Christoferson Group LLC Amherst, NY42KShares$10,0800.01% of portfolio
-
Raymond James & Associates St Petersburg, FL30KShares$7,2000.0% of portfolio
-
Northern Trust Corp Chicago, IL24KShares$5,7680.0% of portfolio
About Virios Therapeutics, Inc.
- Ticker VIRI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,330,400
- Market Cap $4.4M
- Description
- Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...